Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot pla...
Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot platform
About this item
Full title
Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot platform
Publisher
PR Newswire Association LLC
Journal title
PR newswire, 2021-09-28
Language
English
Formats
Publication information
Publisher
PR Newswire Association LLC
Subjects
More information
Alternative Titles
Full title
Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot platform
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_incontextgauss_IBG_A676883111
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_IBG_A676883111
How to access this item
Log in as a Library member